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Abstract
Intestinal carriage of extended-spectrum beta-lactamase (ESBL) -producing bacteria in food-producing animals and contamination of
retail meat may contribute to increased incidences of infections with ESBL-producing bacteria in humans. Therefore, distribution of
ESBL genes, plasmids and strain genotypes in Escherichia coli obtained from poultry and retail chicken meat in the Netherlands was
determined and defined as ‘poultry-associated’ (PA). Subsequently, the proportion of E. coli isolates with PA ESBL genes, plasmids and
strains was quantified in a representative sample of clinical isolates. The E. coli were derived from 98 retail chicken meat samples, a
prevalence survey among poultry, and 516 human clinical samples from 31 laboratories collected during a 3-month period in 2009.
Isolates were analysed using an ESBL-specific microarray, sequencing of ESBL genes, PCR-based replicon typing of plasmids, plasmid
multi-locus sequence typing (pMLST) and strain genotyping (MLST). Six ESBL genes were defined as PA (blaCTX-M-1, blaCTX-M-2, blaSHV-2,
blaSHV-12, blaTEM-20, blaTEM-52): 35% of the human isolates contained PA ESBL genes and 19% contained PA ESBL genes located on IncI1
plasmids that were genetically indistinguishable from those obtained from poultry (meat). Of these ESBL genes, 86% were blaCTX-M-1 and
blaTEM-52 genes, which were also the predominant genes in poultry (78%) and retail chicken meat (75%). Of the retail meat samples,
94% contained ESBL-producing isolates of which 39% belonged to E. coli genotypes also present in human samples. These findings are
suggestive for transmission of ESBL genes, plasmids and E. coli isolates from poultry to humans, most likely through the food chain.
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Introduction
There is a worldwide increase in infections caused by
Gram-negative bacteria producing extended spectrum beta-
lactamases (ESBL), even in a low-resistance country such as
the Netherlands [1]. This is remarkable because the Nether-
lands have low levels of antibiotic usage and have been
successful in controlling nosocomial spread of other multi-
resistant bacteria [2–4].
In contrast to human antibiotic use, antibiotic use in the
poultry industry is higher in the Netherlands than in any
other European country [5]. The prevalence of ESBL-produc-
ing Escherichia coli in the gastrointestinal tract of healthy
food-producing animals, especially poultry, increased from
3% in 2003 to 15% in 2008 and in 2009 ESBL-producing
bacteria were detected in all 26 of 26 broiler farms studied
[6,7]. Furthermore, contamination of retail chicken meat
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with ESBL-producing Gram-negative bacteria has been docu-
mented in several countries [8–10].
For these reasons the poultry industry has been consid-
ered a potential reservoir of ESBL-producing Gram-negative
bacteria that may be acquired by humans through handling
or consumption of contaminated meat. We therefore deter-
mined the distribution of ESBL genes, plasmids and strain
genotypes in E. coli obtained from poultry and retail chicken
meat in the Netherlands and defined these as ‘poultry associ-
ated’ (PA). Subsequently, we quantified the proportion of
E. coli isolates with PA related ESBL genes, plasmids and
strains in a large and representative sample of clinical E. coli
isolates from Dutch patients.
Methods
Isolates
Retail chicken meat. Between April and June 2010, 98 fresh
raw chicken breasts were purchased in 12 stores in Utrecht,
the Netherlands. Seventy-eight of the samples were pur-
chased at nine stores belonging to six supermarket chains
(Dutch market share of 90%) and 20 from three different
butcheries. Information about the region where the chickens
were raised was available for 30 supermarket samples (27%
Netherlands, 73% Benelux). For culture methods see Supple-
mentary material Data S1.
Poultry. The poultry isolates were derived from the Dutch
surveillance programme on antibiotic resistance in bacteria
isolated in food-producing animals in 2006 [11]. The sampling
strategy in this programme aims to obtain annual collections
of E. coli and Salmonella enterica, representative of the Dutch
food-producing animal bacterial populations. Twelve percent
(22 E. coli and 22 S. enterica) of all isolates were cefotaxime
resistant. ESBL genes were identified in 35 of these: 17
(49%) blaCTX-M-1, ten (29%) blaTEM-52, four (11%) blaTEM-20,
three (9%) blaCTX-M-2, and one (3%) blaSHV-2 [12]. The 27
blaCTX-M-1 and blaTEM-52 positive isolates were included.
Human. From 1 February 2009 until 1 May 2009, 31 Dutch
laboratories submitted all E. coli with a positive ESBL screen
test (MIC > 1 mg/L for cefotaxime or ceftazidime or an
ESBL alarm from the Phoenix or Vitek-2 expert system)
[13]. For each isolate the following data were collected: age,
gender, material and institution (hospital, general practi-
tioner (GP), long-term care facility (LTCF)). From each labo-
ratory the first 25 consecutive isolates (if available), one
isolate per patient, were included. The participating labora-
tories are geographically dispersed over the Netherlands
and represent a mixture of secondary and tertiary care hos-
pitals, LTCFs and GPs. The laboratories serve a total of 58
hospitals, covering approximately 45% of all hospital beds in
the Netherlands.
Molecular analyses
The presence of ESBL genes was determined by microarray
analysis [14] and gene sequencing. All human isolates were
investigated by microarray and sequencing was performed on
a random selection of 50%. Among the retail isolates all
morphologically different ESBL-positive E. coli from three
meat samples of each available packaging type (whole breast
or sliced) per store were analysed by sequencing.
Plasmid analysis was performed on a random selection of
human and poultry isolates carrying either a blaCTX-M-1 or a
blaTEM-52 gene. All plasmids were characterized using PCR-
based replicon typing (PBRT) [12,15]. The association between
ESBL gene and plasmids was determined either by Southern
blot hybridization or transformation [12]. IncI1 plasmids were
typed by plasmid multi-locus sequence typing (pMLST) [16].
Isolates were genotyped by MLST (http://www.mlst.net).
Among the human isolates 27 were genotyped: isolates with
documented presence of blaCTX-M-1 or blaTEM-52 genes on an
IncI1 plasmid (n = 15) and a random selection (n = 12) of all
other isolates carrying a blaCTX-M-1 or blaTEM-52.
Among the poultry isolates, all 22 isolates with either
blaCTX-M-1 or blaTEM-52 located on IncI1 plasmids were
selected for genotyping.
From the retail isolates with a blaCTX-M-1, blaSHV-12 or blaTEM-
52 gene, 23 isolates were randomly selected for genotyping.
Results
Distribution of ESBL genes
Retail chicken meat. Of the 98 chicken retail meat samples,
92 (94%) samples contained at least one E. coli isolate with
an ESBL phenotype, yielding 163 isolates (average number
per sample 2; range 1–4). From 48 samples, 81 isolates cul-
tured were further analysed. The array confirmed the pres-
ence of an ESBL gene in all isolates: 40 CTX-M-1-group, 21
TEM-3-group, 13 SHV-4-group, three SHV-2-group, three
CTX-M-2-group and one TEM-19-group. By sequencing one
ESBL gene was identified in each of these six different ESBL
groups: blaCTX-M-1, blaTEM-52, blaSHV-12, blaSHV-2, blaCTX-M-2
and blaTEM-20, respectively. These genes were considered as
PA. The blaCTX-M-1 and blaTEM-52 accounted for 75% of the
genes (Table 1). The blaSHV-12 gene was not detected in
poultry in 2006, but has been detected in poultry isolates
obtained in 2009 (D. Mevius, personal communication).
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Human samples. In the study period, 1017 E. coli were ESBL
screen positive, from which 516 were included (Fig. 1). The
median number per laboratory was 17 (range 7–25) and per
hospital was 10 (range 0–21). The proportion of isolates
derived from non-university hospitals was 54%, from GPs
was 30%, from university medical centres was 6% and from
LTCFs was 5% (5% unknown).
Based on the microarray results, 409 (79%) isolates con-
tained an ESBL gene, and in 344 (84%) of these the ESBL
genes were potentially PA (Fig. 1; rows A and B). Sequence
results of 208 randomly selected isolates identified five
(blaCTX-M-1, blaCTX-M-2, blaTEM-52, blaSHV-2 or blaSHV-12) of the
six PA genes (Fig. 1; row C). The blaTEM-20 gene was not
detected in any of the human isolates.
The proportion of blaCTX-M-1 and blaTEM-52 genes among
all ESBL genes detected in clinical isolates was similar in five
different age groups (0–4, 20–39, 40–59, 60–79, >80 years)
and in four different geographic regions. The proportion of
blaCTX-M-1 and blaTEM-52 genes was similar among isolates
submitted by GPs (33%; 23/70; 95% CI: 22–44), non-aca-
demic hospitals (26%; 27/104; 95% CI: 18–34), LTCFs (26%;
4/14; 95% CI: 5–52) and academic hospitals (37%; 3/8; 95%
CI: 4–71). The 27 isolates that were MLST genotyped were
obtained from 17 different laboratories. Of these, 23 (85%)
were urine isolates, 19 (70%) came from GPs and none came
from the same facility.
Plasmid analysis and isolate typing
Human isolates. The PBRT was performed on 15 of 51
human isolates with a blaCTX-M-1 gene and on six of 14
human isolates with a blaTEM-52 gene (Table 3; Fig. 1; rows C
and D). Nine of the 15 blaCTX-M-1 genes and all six of the
blaTEM-52 (i.e. 15/21; 71%) were located on an IncI1 plasmid.
The pMLST demonstrated that seven of the nine blaCTX-M-
1/IncI1 plasmids (78%) belonged to pMLST Clonal Complex
CC7 and pMLST sequence type ST7 (CC7/ST7), one to
CC3/ST3 and one to CC31/ST35 (Table 3; Fig. 1; row E).
Isolate genotyping demonstrated that six of the seven
CC7/ST7 isolates belonged to the PA MLST types: ST10
(n = 1), ST58 (n = 3), ST117 (n = 2) (Table 3; Fig. 1; row F).
The pMLST analysis of the six blaTEM-52/IncI1 plasmids
demonstrated that five were ST36 (CC5) and one was ST10
(CC5), which differ in a single locus (one mutation in the
sogS-gene).
Genotyping revealed that two isolates belonged to PA
ST10 (Table 3; Fig. 1; rows E and F).
Typing by MLST of 13 randomly selected isolates demon-
strated among ten blaCTX-M-1 positive isolates three PA
genotypes (ST117, ST57, ST354) and among three blaTEM-52
positive isolates one PA genotype (ST23).
Poultry isolates. The PBRT was performed on all 27 blaCTX-M-1
and blaTEM-52 containing E. coli and Salmonella. Sixteen (of 17)
blaCTX-M-1 and six (of 10) blaTEM-52 genes were located on an
IncI1 plasmid (22/27; 81%) (Table 3).
Plasmid MLST of the 16 blaCTX-M-1/IncI1 plasmids demon-
strated that 12 (75%) (eight E. coli, four Salmonella) belonged
to CC7/ST7 and one to CC7/ST30 (ST30 is a single-locus
variant of ST7). One plasmid belonged to CC3/ST3 and two
were non-typable.
Genotyping by MLST of the eight CC7/ST7 E. coli revealed
ST10, ST48, ST58, ST117 and four STs not found among clin-
ical or meat samples.
hepMLSTofthesixblaTEM-52/IncI1plasmidsdemonstratedthat
all six (twoE. coli, fourSalmonella)belonged toCC5/ST10.Oneof
theE. colibelongedtogenotypeST10.
Retail meat. Isolate genotyping was performed on 23 retail
E. coli [nine blaCTX-M-1 (five stores), seven blaTEM-52 (four
stores), seven blaSHV-12 (five stores)]. Nine (39%) belonged
to MLST types also found in human isolates: ST10 (n = 4),
ST23 (n = 1), ST57 (n = 1), ST117 (n = 2), and ST354
(n = 1). One isolate belonged to ST48, which was like ST10
and ST117 also identified among the poultry isolates.
Genetic correlation between human, chicken meat and poultry iso-
lates. These data revealed four sets of E. coli isolates of
human and animal origin with indistinguishable ESBL genes,
plasmids and isolate genotypes: (i) E. coli ST10 with blaCTX-M-1
and IncI1/ST7 as human blood culture isolate and a poultry
isolate, (ii) E. coli ST58 with blaCTX-M-1 and IncI1/ST7 as three
TABLE 1. Distributions of extended-spectrum beta-lactam-
ase (ESBL) genes in Escherichia coli and Salmonella spp.
isolates from poultry, poultry retail meat samples and from
human origin based on array results combined with
sequence results
Poultry-associated
ESBL genes
Poultry
Poultry meat
samplesa Humana
n = 35 n = 81 n = 409
blaCTX-M-1 (%) 49 49 24
blaTEM-52 (%) 29 26 6
bla SHV-12 (%) 0 16 4
blaSHV-2 (%) 11 4 0.4
blaCTX-M-2 (%) 9 4 0.2
blaTEM-20 (%) 3 1 0
Total (%) 100 100 35
The number of isolates analysed by array among meat and human isolates was
81 and 409, respectively. The number of isolates analysed by sequencing among
poultry, meat and human isolates was 35 (100%), 81 (100%) and 208 (51%),
respectively.
aPercentages are extrapolations based on array results and sequence results.
For calculation of the percentages see also Fig. 1. For example percentage of
blaCTX-M-1 in human isolates = 0.84 · 0.85 · 0.34 = 24%.
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human urine isolates from three different laboratories and a
poultry isolate, (iii) E. coli ST117 with blaCTX-M-1 and IncI1/
ST7 as two human isolates from different laboratories and a
poultry isolate, and (iv) E. coli ST10 with blaTEM-52 and IncI/
ST10/36 was detected in two human urine samples from two
laboratories and a poultry isolate. These four MLST geno-
type/ESBL gene combinations were also found in retail meat
isolates (Table 3).
Quantification of the proportion of PA genes, plasmids and
strains in human isolates
Based on these data we quantified the proportion of human
ESBL-producing E. coli with PA genes, plasmids and isolates
(Fig. 1 and Table 2).
On the level of ESBL genes 35% (95% CI: 30–39%) of the
human ESBL isolates contained PA ESBL genes and blaCTX-M-1
and blaTEM-52 accounted for the majority (30/35; 86%)
(Tables 1 and 2).
Plasmid analysis was limited to blaTEM-52-positive and
blaCTX-M-1-positive isolates. On the level of these two ESBL
genes and plasmid family (i.e. IncI1) the proportion of human
isolates genetically related to poultry isolates was 20% (95%
CI: 17–25%). On the level of these ESBL genes, the presence
of IncI1 plasmid and similar plasmid sequence types (CC3,
CC5 or CC7), this proportion was 19% (95% CI: 15–23%).
Finally, at the level of these ESBL genes, plasmid typing and
MLST of the isolate, this proportion was 11% (95% CI: 8–
14%) (Table 2).
Of the five ESBL-producing E. coli bloodstream isolates
that were sequenced two contained a PA ESBL gene: blaCTX-M-1
and blaTEM-52. The blaCTX-M-1 was located on the same plas-
mid (IncI1), from the same plasmid sequence type (CC7),
516 non-repeat isolates (first 25 per lab)
1.017 E. coli human clinical isolates with a positive ESBL screen test 691 (68%) urine samples
125 (12%) screening samples
81 (8%) wounds or abscesses
57 (6%) respiratory tract samples 
27 (3%) blood
36 (4%) other
409 (79%) isolates contained an ESBL-gene isolates based on array results 
Other 65 (16%)344 (84%) isolates possibly contained a poultry associated ESBL gene A
CTX-M-1f*
294 (85%)
TEM-3 gr
30 (9%) 
SHV-4 gr
15 (4%)
SHV-2 gr
3 (1%)
CTX-M-2f
2 (1%)
208 randomly selected isolates sequenced 
79/180 isolates contained a poultry associated (PA) gene 1/28 PA-gene**
B
CTX-M-1***
51/149 (34%)
TEM-52 
14/17 (82%)
SHV-12 
10/10 (100%)
SHV-2   2/3 (66%)
SHV-12 1/3 (31%)
CTX-M-2
1/1 (100%)
60 (76%) urine samples
7 (9%) screening samples 
5 (6%)  wounds or abscesses
3 (4%) respiratory tract samples 
2 (2%) blood
2 (2%) other
Proportion of isolates with poultry associated gene on IncI1 plasmid (Table 3) 
C
Proportion of isolates with poultry associated IncI1 plasmid belonging to complexes CC7, CC5 or CC3 (Table 3) 
CTX-M-1
9/15 (60%)
TEM-52
6/6 (100%)D
CTX-M-1
8/9 (89%)
TEM-52
6/6 (100%)
Proportion of isolates with poultry associated IncI1 plasmid complex CC7, CC5 or CC3 and belonging to a 
poultry-associated MLST strain type (ST10, ST58 or ST117) (Table 3)
E
CTX-M-1
6/8 (75%)
TEM-52
2/6 (33%)F
FIG. 1. Schematic view of methods and numbers of isolates used to determine the proportion of human Escherichia coli isolates with poultry-
associated extended-spectrum beta-lactamase (ESBL) genes, plasmids and isolate genotypes. Percentages in bold were used to determine propor-
tions (Table 2). *Nine isolates harboured next to the CTX-M-1 group another possibly poultry-associated gene: SHV-4-group gene (n = 5), a
TEM-3-group gene (n = 3) and SHV-2-group gene (n = 1). **One isolate carried according to the array an ESBL gene of the SHV-31 group but
sequencing results indicated the presence of a blaSHV-12. ***Three isolates harboured two poultry-associated genes: blaCTX-M-1 plus blaSHV-12
(n = 2) and blaCTX-M-1 plus blaTEM-52 (n = 1).
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and belonged to the same MLST cluster (ST10) as was
detected in a poultry isolate (Table 3). No plasmid analysis
was performed on the blaTEM-52-positive blood culture iso-
late, but all other isolates with blaTEM-52 that were investi-
gated had the same plasmids as found in poultry isolates
(Fig. 1; rows D and E).
Discussion
In a representative sample of human ESBL-positive E. coli iso-
lates in the Netherlands, 35% contained ESBL genes and 19%
contained ESBL genes located on plasmids that were geneti-
cally indistinguishable from those obtained in poultry isolates.
The majority of these ESBL genes (86%) were blaCTX-M-1 and
blaTEM-52 genes, also the predominant genes in poultry (77%)
and retail chicken meat (75%). Furthermore, 94% of a repre-
sentative sample of chicken meat was contaminated with
ESBL-producing E. coli, of which 39% belonged to genotypes
also found in human samples.
These findings are suggestive for transmission of ESBL-
producing E. coli from poultry to humans, most likely through
the food chain. Although our findings do not unequivocally
prove that the poultry reservoir is the source of infections
in humans, there are four lines of circumstantial evidence
that do support such a sequence of events.
First, the potential of animal-derived Enterobacteriaceae
to cause infections in humans has been established in com-
munity outbreaks of Salmonella and enteropathogenic E. coli
[17], and associations between E. coli colonization and
infection in humans and exposure to retail chicken and other
food sources have been reported [18–20]).
Second, the prevalence of blaCTX-M-1 genes (24%) and
blaTEM-52 (6%) among human E. coli is higher in the Nether-
lands than in most other countries [21–26].
Third, the increase of blaCTX-M-1 and blaTEM-52 genes
among human E. coli corroborates with an increase of these
ESBL genes in poultry isolates in the Netherlands. The preva-
lence of cefotaxime-resistant E. coli in Dutch poultry started
to increase in 2003 [6] and in a human surveillance
study among 21 laboratories in the Netherlands in 2006,
proportions of blaCTX-M-1 and blaTEM-52 E. coli producers
were 9% and 3%, respectively (Sandra Bernards; personal
communication).
Fourth, in one study people working with poultry seemed
to have a higher risk for intestinal carriage of ESBL-producing
bacteria [7].
Our study was restricted to Dutch patients, poultry and
poultry meat products. Yet, ESBL carriage by poultry and
contamination of retail meat with ESBL-producing bacteria
has also been demonstrated in other European countries
[8,9,25–29].
Our study has limitations. First, the spectrum of PA ESBL
genes was based on a single study in poultry in 2006 and the
analysis of 98 retail chicken meat samples in 2010, and this
spectrum was compared with human isolates obtained
between February and May 2009. Naturally, it is impossible
to directly link carriage among poultry in 2006 to contami-
nated meat samples in 2010 to infected humans in 2009. Yet,
although the ESBL epidemiology is rapidly evolving, it seems
unlikely that the spectrum of genes present in these three
compartments has changed dramatically over the period of
4 years. In fact, the five genes identified in poultry in 2006
were all identified on meat in 2010, in both compartments
blaCTX-M-1 and blaTEM-52 genes accounted for 78% and 75%
of ESBL genes and in both compartments strains with the
same genotype were detected.
Second, the plasmid analysis was limited to a small selec-
tion of isolates with blaCTX-M-1 and blaTEM-52 genes, only. The
latter was a consequence of the extreme labour-intensity of
these analyses.
Strengths of our study include the detailed molecular anal-
yses and the inclusion of human isolates from a nationwide
surveillance programme covering all aspects of the healthcare
system and with an unbiased selection of isolates allowing,
for the first time, the possibility to quantify the association
between genetic relationships and incidence of infections in
humans.
For example, during the study period 27 patients had an
E. coli bacteraemia with a positive ESBL screen test. If,
TABLE 2. The proportion of human extended-spectrum
beta-lactamase (ESBL) -positive Escherichia coli isolates that
is genetically related to ESBL-positive poultry isolates on
the level of gene, plasmid and strain genotypea
Level of genetic typing
% of human isolates with poultry
associated genetic elementa
ESBL genes (blaCTX-M-1, blaTEM-52,
bla SHV-12, blaSHV-2 and blaCTX-M-2)
35% (see Table 1)
blaCTX-M-1 and blaTEM-52 genes 30% (23.7% blaCTX-M-1; 6.2% blaTEM-52)
blaCTX-M-1 and blaTEM-52 genes on IncI1
plasmid
20% (14.2% blaCTX-M-1; 6.2% blaTEM-52)
blaCTX-M-1 and blaTEM-52 genes on Inc1
plasmid belonging to complex CC7
or CC3 and CC5 resp.
19% (12.6% blaCTX-M-1; 6.2% blaTEM-52)
blaCTX-M-1 and blaTEM-52 genes on Inc1
plasmid belonging to complex CC7 or
CC3 and CC5 resp.
in a poultry-associated MLST strain
(ST10, ST58 or ST117)
11% (9.5% blaCTX-M-1; 2.0% blaTEM-52)
MLST, multi-locus sequence typing.
For example percentage of blaTEM-52 genes on IncI1 plasmid belonging to
complex CC5 in to poultry identical MLST strains = 0.84 (row A) · 0.09 (row
B) · 0.82 (row C) · 1 (row D) · 1 (row E) · 0.33 (row F) = 2.0%.
aPercentages are extrapolations based on array results, sequence results and
results of plasmid characterization and strain typing. For calculation of the
percentages see Fig. 1.
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based on our results, 79% of these isolates contained an
ESBL gene, this would imply 21 patients with ESBL bactera-
emia. The ESBL genes from five of these isolates were
sequenced and at least one and possibly two were PA.
When extrapolated, at least one of 21 (5%), but possibly
eight (38%) patients would have suffered an episode of PA
E. coli bacteraemia. As the participating laboratories cover
nearly half of Dutch hospital beds this would mean
between two and 16 patients in the Netherlands between
February and May 2009.
TABLE 3. Results of strain (multi-locus sequence typing) and plasmid typing (Inc-group and plasmid multi-locus sequence typ-
ing) of blaCXT-M-1- and blaTEM-52-producing Escherichia coli isolates from human patients and E. coli and Salmonella enterica iso-
lates from poultry sources
ESBL-
gene
Strain
code Origin Species Material
Plasmid typing IncI1 typing E. coli strain typing
ESBL
localization
Plasmid
size (kb)
Clonal
complex
Sequence
type
Sequence
type
blaCTX-M-1 148 Human E. coli Blood IncI1 100 CC7 ST7 10
38.27 Poultry E. coli Caecum IncI1 88 CC7 ST7 10
53a, 54a Retail E. coli Chicken meat n.d. n.d. n.d. n.d. 10 (n = 2)
1365 Human E. coli Urine IncI1 100 CC7 ST7 58
1350 Human E. coli Urine IncI1 100 CC7 ST7 58
1240 Human E. coli Urine IncI1 95 CC7 ST7 58
38.16 Poultry E. coli Caecum IncI1 100 CC7 ST7 58
1240 Human E. coli Urine n.d. n.d. n.d. n.d. 58
897 Human E. coli Respiratory tract IncI1 100 CC7 ST7 117
1047 Human E. coli Rectal swab IncI1 100 CC7 ST7 117
38.52 Poultry E. coli Caecum IncI1 100 CC7 ST7 117
623 Human E. coli Urine n.d. n.d. n.d. n.d. 117
39.26 Poultry E. coli Caecum IncI1 100 CC7 ST7 48
38.53 Poultry E. coli Caecum IncI1 100 CC7 ST7 155
38.49 Poultry E. coli Caecum IncI1 97 CC7 ST7 641
39.02 Poultry E. coli Caecum IncI1 110 CC7 ST7 665
39.05 Poultry E. coli Caecum IncI1 97 CC7 ST7 752
1247 Human E. coli Urine IncI1 100 CC7 ST7 767
162.03 Poultry S. Javab Unknown IncI1 97 CC7 ST7 n.d.
175.77 Poultry S. Infantis Unknown IncI1 100 CC7 ST7 n.d.
187.45 Poultry S. Infantis Caecum IncI1 100 CC7 ST7 n.d.
187.46 Poultry S. Infantis Caecum IncI1 100 CC7 ST7 n.d.
39.51 Poultry E. coli Caecum IncI1 95 CC7 ST30 155
691 Human E. coli Urine IncI1 90 CC31 ST35 131
1503 Human E. coli Urine n.d. n.d. n.d. n.d. 131
39.47 Poultry E. coli Meat IncI1 97 n.d. Non-typablea 117
186.74 Poultry S. Javab Caecum IncI1 97 n.d. Non-typablea n.d.
450 Human E. coli Urine IncI1 95 CC3 ST3 167
186.27 Poultry S. Agona Caecum IncI1 110 CC3 ST3 n.d.
990 Human E. coli Urine IncB/O 95 n.d. n.d. n.d.
1198 Human E. coli Urine IncB/O 95 n.d. n.d. n.d.
312 Human E. coli Urine IncB/O 100 n.d. n.d. n.d.
60 Human E. coli Urine IncN 30 n.d. n.d. n.d.
1455 Human E. coli Urine IncN 35 n.d. n.d. n.d.
627 Human E. coli Urine Non-typable 30 n.d. n.d. n.d.
13, 591, 416, 152, 179 Human E. coli Urine n.d. n.d. n.d. n.d. 69 (n = 2), 57, 162
666, 152, 387 Human E. coli Urine n.d. n.d. n.d. n.d. 354, 453, 545
52a, 54a, 72a, 71 Retail E. coli Chicken meat n.d. n.d. n.d. n.d. 23 (n = 2), 624, 1564
60, 61, 63a, 69, 39b Retail E. coli Chicken meat n.d. n.d. n.d. n.d. 1594 (n = 2), 1901, n.t. (n = 2)
blaTEM-52 38.34 Poultry E. coli Caecum IncI1 97 CC5 ST10 10
320 Human E. coli Urine IncI1 95 CC5 ST36 10
681 Human E. coli Urine IncI1 95 CC5 ST36 10
85b Retail E. coli Chicken meat n.d. n.d. n.d. n.d. 10
68 Human E. coli Urine IncI1 95 CC5 ST10 156
39.76 Poultry E. coli Caecum IncI1 90 CC5 ST10 752
166.01 Poultry S. Javab Meat IncI1 82 CC5 ST10 n.d.
166.22 Poultry S. Javab Meat IncI1 82 CC5 ST10 n.d.
162.19 Poultry S. Infantis Unknown IncI1 82 CC5 ST10 n.d.
173.44 Poultry S. Infantis Caecum IncI1 90 CC5 ST10 n.d.
85 Human E. coli Urine IncI1 90 CC5 ST36 131
91 Human E. coli Urine IncI1 90 CC5 ST36 Non-typablec
1362 Human E. coli Urine IncI1 90 CC5 ST36 453
229, 194 Human E. coli Urine n.d. n.d. n.d. n.d. 23, 744
45a, 47a, 83a, 90, 95a Retail E. coli Chicken meat n.d. n.d. n.d. n.d. 23, 48, 117, 1403, n.t.
ESBL, extended-spectrum beta-lactamase; n.d., not determined; n.t., non-typable.
aFour sequences in conformance with pMLST ST7, but for locus ardA no sequence results were obtained.
bSalmonella enterica serovar paratyphi B variant Java.
cSix sequences in conformance with MLST ST767, but for locus icd no sequence results were obtained.
This table shows the genetic correlation between E. coli from patients and retail meat and E. coli and Salmonella from poultry carrying blaCTX-M-1 or blaTEM-52. The E. coli iso-
lates were compared by Multi Locus Sequence Typing (http://www.mlst.net). All IncI1 plasmids were compared by pMLST and three genetically related clusters were found,
indicated by bold face text: CC7, CC3 and CC5. There were four sets of E. coli isolates, of human and animal origin, with indistinguishable ESBL genes, plasmids and isolated
genotypes, indicated in the table by different shading patterns (light grey, MLST ST10 (n = 2); middle grey, MLST 58; dark grey, MLST 117).
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